| Purpose | Announcement Date | Meeting Date |
|---|---|---|
| EGM | 12 Jan 2026 | 4 Feb 2026 |
| Beta Drugs Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on February 04, 2026 (As Per NSE Announcement Dated On : 30.01.2026) Beta Drugs Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on February 04, 2026. Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on February 04, 2026. Further, the company has informed the Exchange regarding voting results. (As Per NSE Announcement Dated On : 04.02.2026) Beta Drugs Limited has informed the Exchange about General Updates (As Per NSE Announcement Dated on : 16.03.2026) Beta Drugs Limited has informed the Exchange about General Updates (As Per NSE Announcement Dated on : 20.03.2026) Beta Drugs Limited has informed the Exchange about General Updates (As Per NSE Announcement Dated On : 03.04.2026) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
